Margaret Cunningham
Corporate Officer/Principal chez Dalhousie University
Profil
Margaret Cunningham is currently the Dean at Dalhousie University since 2010.
Prior to this, she worked as an Independent Non-Executive Director at Telesta Therapeutics, Inc. from 2012 to 2013.
She also worked as a Professor at Queen's University of Belfast.
Dr. Cunningham holds a doctorate degree from Texas A&M University and an MBA from the University of Calgary.
Postes actifs de Margaret Cunningham
| Sociétés | Poste | Début |
|---|---|---|
| Dalhousie University | Corporate Officer/Principal | 01/04/2010 |
Anciens postes connus de Margaret Cunningham
| Sociétés | Poste | Fin |
|---|---|---|
| TELESTA THERAPEUTICS INC | Directeur/Membre du Conseil | 05/11/2013 |
| Queen's University of Belfast | Corporate Officer/Principal | - |
Formation de Margaret Cunningham
| Texas A&M University | Doctorate Degree |
| University of Calgary | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Telesta Therapeutics, Inc.
 Telesta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Telesta Therapeutics, Inc. is a biotechnology company, which focuses on the licensing/acquisition and development of transformational therapeutics for the treatment of serious human diseases, such as cancer, immune diseases, and targeted rare diseases. The company was founded by Graeme McRae in 1979 and is headquartered in Pointe-Claire, Canada. | Health Technology |
